chrX-80669707-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_153252.5(BRWD3):c.*6902G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00677 in 111,346 control chromosomes in the GnomAD database, including 6 homozygotes. There are 201 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0068 ( 6 hom., 201 hem., cov: 23)
Consequence
BRWD3
NM_153252.5 3_prime_UTR
NM_153252.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.05
Genes affected
BRWD3 (HGNC:17342): (bromodomain and WD repeat domain containing 3) The protein encoded by this gene contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene are associated with a spectrum of cognitive disabilities and X-linked macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant X-80669707-C-T is Benign according to our data. Variant chrX-80669707-C-T is described in ClinVar as [Benign]. Clinvar id is 368678.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00677 (754/111346) while in subpopulation AFR AF= 0.0224 (688/30712). AF 95% confidence interval is 0.021. There are 6 homozygotes in gnomad4. There are 201 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRWD3 | NM_153252.5 | c.*6902G>A | 3_prime_UTR_variant | 41/41 | ENST00000373275.5 | NP_694984.5 | ||
BRWD3 | XM_005262113.4 | c.*6902G>A | 3_prime_UTR_variant | 40/40 | XP_005262170.1 | |||
BRWD3 | XM_017029384.2 | c.*6902G>A | 3_prime_UTR_variant | 30/30 | XP_016884873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRWD3 | ENST00000373275.5 | c.*6902G>A | 3_prime_UTR_variant | 41/41 | 1 | NM_153252.5 | ENSP00000362372 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00679 AC: 756AN: 111295Hom.: 6 Cov.: 23 AF XY: 0.00600 AC XY: 201AN XY: 33517
GnomAD3 genomes
AF:
AC:
756
AN:
111295
Hom.:
Cov.:
23
AF XY:
AC XY:
201
AN XY:
33517
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00677 AC: 754AN: 111346Hom.: 6 Cov.: 23 AF XY: 0.00599 AC XY: 201AN XY: 33578
GnomAD4 genome
AF:
AC:
754
AN:
111346
Hom.:
Cov.:
23
AF XY:
AC XY:
201
AN XY:
33578
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual disability, X-linked 93 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at